The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The Resistome of Pseudomonas aeruginosa in Relationship to Phenotypic Susceptibility
Open accessAbstract
Many clinical isolates of Pseudomonas aeruginosa cause infections that are difficult to eradicate due to their resistance to a wide variety of antibiotics. Key genetic determinants of resistance were identified through genome sequences of 390 clinical isolates of P. aeruginosa , obtained from diverse geographic locations collected between 2003 and 2012 and were related to microbiological susceptibility data for meropenem, levofloxacin, and amikacin. β-Lactamases and integron cassette arrangements were enriched in the established multidrug-resistant lineages of sequence types ST111 (predominantly O12) and ST235 (O11). This study demonstrates the utility of next-generation sequencing (NGS) in defining relevant resistance elements and highlights the diversity of resistance determinants within P. aeruginosa . This information is valuable in furthering the design of diagnostics and therapeutics for the treatment of P. aeruginosa infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models
Stamatakis, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl446 · Cited by 15,582
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
CRISPR/Cas, the Immune System of Bacteria and Archaea
Horvath, P., & Barrangou, R. (2010) · Science · doi:10.1126/science.1179555 · Cited by 2,465
BIGSdb: Scalable analysis of bacterial genome variation at the population level
Jolley, K. A., & Maiden, M. C. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-595 · Cited by 2,368
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2749 · Cited by 919
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Snitkin, E. S., Zelazny, A. M., Thomas, P. J., Stock, F., Program, N. C. S., Henderson, D. K., Palmore, T. N., & Segre, J. A. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004129 · Cited by 863
Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system
Bondy-Denomy, J., Pawluk, A., Maxwell, K. L., & Davidson, A. R. (2013) · Nature · doi:10.1038/nature11723 · Cited by 830
Origins of the E. coli Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
Rasko, D. A., Webster, D. R., Sahl, J. W., Bashir, A., Boisen, N., Scheutz, F., Paxinos, E. E., Sebra, R., Chin, C.-S., Iliopoulos, D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106920 · Cited by 823
Pseudomonas aeruginosa – a phenomenon of bacterial resistance
Strateva, T., & Yordanov, D. (2009) · Journal of Medical Microbiology · doi:10.1099/jmm.0.009142-0 · Cited by 803
Mellmann, A., Harmsen, D., Cummings, C. A., Zentz, E. B., Leopold, S. R., Rico, A., Prior, K., Szczepanowski, R., Ji, Y., Zhang, W., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022751 · Cited by 768
Rapid Whole-Genome Sequencing for Investigation of a Neonatal MRSA Outbreak
Köser, C. U., Holden, M. T. G., Ellington, M. J., Cartwright, E. J. P., Brown, N. M., Ogilvy-Stuart, A. L., Hsu, L. Y., Chewapreecha, C., Croucher, N. J., Harris, S. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109910 · Cited by 654
Harris, S. R., Cartwright, E. J., Török, M. E., Holden, M. T., Brown, N. M., Ogilvy-Stuart, A. L., Ellington, M. J., Quail, M. A., Bentley, S. D., Parkhill, J., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70268-2 · Cited by 564
Global dissemination of a multidrug resistant Escherichia coli clone
Petty, N. K., Ben Zakour, N. L., Stanton-Cook, M., Skippington, E., Totsika, M., Forde, B. M., Phan, M.-D., Gomes Moriel, D., Peters, K. M., Davies, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322678111 · Cited by 558
Ray: Simultaneous Assembly of Reads from a Mix of High-Throughput Sequencing Technologies
Boisvert, S., Laviolette, F., & Corbeil, J. (2010) · Journal of Computational Biology · doi:10.1089/cmb.2009.0238 · Cited by 539
Self-citationCurran, B., Jonas, D., Grundmann, H., Pitt, T., & Dowson, C. G. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5644-5649.2004 · Cited by 509
Multidrug-Resistant Enterococci Lack CRISPR- cas
Palmer, K. L., & Gilmore, M. S. (2010) · mBio · doi:10.1128/mbio.00227-10 · Cited by 437
Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe
Souli, M., Galani, I., & Giamarellou, H. (2008) · Eurosurveillance · doi:10.2807/ese.13.47.19045-en · Cited by 436
Of Pseudomonas, porins, pumps and carbapenems
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.3.247 · Cited by 391
[15] Effective protein sequence comparison
Pearson, W. R. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)66017-0 · Cited by 346
DeLeo, F. R., Chen, L., Porcella, S. F., Martens, C. A., Kobayashi, S. D., Porter, A. R., Chavda, K. D., Jacobs, M. R., Mathema, B., Olsen, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321364111 · Cited by 329
Zankari, E., Hasman, H., Kaas, R. S., Seyfarth, A. M., Agerso, Y., Lund, O., Larsen, M. V., & Aarestrup, F. M. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks496 · Cited by 325
Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Function of Pseudomonas Porins in Uptake and Efflux
Hancock, R. E. W., & Brinkman, F. S. L. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160310 · Cited by 319
Stoesser, N., Batty, E. M., Eyre, D. W., Morgan, M., Wyllie, D. H., Del Ojo Elias, C., Johnson, J. R., Walker, A. S., Peto, T. E. A., & Crook, D. W. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt180 · Cited by 308
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Rodríguez-Martínez, J.-M., Poirel, L., & Nordmann, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00574-09 · Cited by 307
Cady, K. C., Bondy-Denomy, J., Heussler, G. E., Davidson, A. R., & O'Toole, G. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.01184-12 · Cited by 287
Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7
Roy, P. H., Tetu, S. G., Larouche, A., Elbourne, L., Tremblay, S., Ren, Q., Dodson, R., Harkins, D., Shay, R., Watkins, K., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008842 · Cited by 284
Self-citationPawluk, A., Bondy-Denomy, J., Cheung, V. H. W., Maxwell, K. L., & Davidson, A. R. (2014) · mBio · doi:10.1128/mbio.00896-14 · Cited by 263
Sader, H. S., Farrell, D. J., Flamm, R. K., & Jones, R. N. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.007 · Cited by 248
Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting
Navon-Venezia, S., Ben-Ami, R., & Carmeli, Y. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000171920.44809.f0 · Cited by 242
Ouellette, M., Bissonnette, L., & Roy, P. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7378 · Cited by 238
Self-citationMiller, A. K., Brannon, M. K., Stevens, L., Johansen, H. K., Selgrade, S. E., Miller, S. I., Høiby, N., & Moskowitz, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05391-11 · Cited by 224
Progress on the development of rapid methods for antimicrobial susceptibility testing
Pulido, M. R., Garcia-Quintanilla, M., Martin-Pena, R., Cisneros, J. M., & McConnell, M. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt253 · Cited by 211
Rapid Bacterial Whole-Genome Sequencing to Enhance Diagnostic and Public Health Microbiology
Reuter, S., Ellington, M. J., Cartwright, E. J. P., Köser, C. U., Török, M. E., Gouliouris, T., Harris, S. R., Brown, N. M., Holden, M. T. G., Quail, M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.7734 · Cited by 206
Sobel, M. L., McKay, G. A., & Poole, K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3202-3207.2003 · Cited by 179
Barnard, F. M., & Maxwell, A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1994-2000.2001 · Cited by 160
Maâtallah, M., Cheriaa, J., Backhrouf, A., Iversen, A., Grundmann, H., Do, T., Lanotte, P., Mastouri, M., Elghmati, M. S., Rojo, F., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025617 · Cited by 154
Li, X.-Z., Poole, K., & Nikaido, H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.27-33.2003 · Cited by 144
Bruchmann, S., Dötsch, A., Nouri, B., Chaberny, I. F., & Häußler, S. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-12 · Cited by 144
Type II Topoisomerase Mutations in Ciprofloxacin-Resistant Strains of Pseudomonas aeruginosa
Mouneimné, H., Robert, J., Jarlier, V., & Cambau, E. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.62 · Cited by 134
Rau, M. H., Marvig, R. L., Ehrlich, G. D., Molin, S., & Jelsbak, L. (2012) · Environmental Microbiology · doi:10.1111/j.1462-2920.2012.02795.x · Cited by 115
de Santi, M. P., Casella, T., Oliveira, M. G. D. L., Rubio, F. G., Nogueira, M. L., de Almeida, M. T. G., & Nogueira, M. C. L. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-176 · Cited by 104
Jeukens, J., Boyle, B., Kukavica‐Ibrulj, I., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087611 · Cited by 100
Emergence of resistance to imipenem in Pseudomonas aeruginosa
Lynch, M. J., Drusano, G. L., & Mobley, H. L. T. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.12.1892 · Cited by 94
Hiroshi Yoneyama, C., & Nakae, T. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2385 · Cited by 80
Witney, A. A., Gould, K. A., Pope, C. F., Bolt, F., Stoker, N. G., Cubbon, M., Bradley, C. R., Fraise, A. P., Breathnach, A. S., Butcher, P. D., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12528 · Cited by 79
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa
Yoshida, H., Nakamura, M., Bogaki, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1273 · Cited by 75
Card, R. M., Zhang, J., Das, P., Cook, C. J., Woodford, N., & Anjum, M. F. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01223-12 · Cited by 74
Rapid Detection of Antibiotic-Resistant Organism Carriage for Infection Prevention
Diekema, D. J., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit038 · Cited by 69
Okamoto, K., Gotoh, N., & Nishino, T. (2002) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-002-0193-7 · Cited by 66
VIM-2–producing Multidrug-Resistant Pseudomonas aeruginosa ST175 Clone, Spain
Viedma, E., Juan, C., Villa, J., Barrado, L., Orellana, M. Á., Sanz, F., Otero, J. R., Oliver, A., & Chaves, F. (2012) · Emerging Infectious Diseases · doi:10.3201/eid1808.111234 · Cited by 62
Ochs, M. M., Lu, C., Hancock, R. E. W., & Abdelal, A. T. H. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.17.5426-5432.1999 · Cited by 61
Tuite, N. L., Reddington, K., Barry, T., Zumla, A. I., & Enne, V. I. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku083 · Cited by 49
Lee, J.-Y., Na, I. Y., Park, Y. K., & Ko, K. S. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt531 · Cited by 47
Smith, J. D., Kumarasiri, M., Zhang, W., Hesek, D., Lee, M., Tóth, M., Vakulenko, S. B., Fisher, J. F., Mobashery, S., & Chen, Y. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00505-13 · Cited by 47
Warren, A., Boulianne-Larsen, C. M., Chandler, C. B., Chiotti, K., Kroll, E., Miller, S. R., Taddéi, F., Sermet‐Gaudelus, I., Ferroni, A., McInnerney, K., et al. (2011) · Infection and Immunity · doi:10.1128/iai.05282-11 · Cited by 47
Potential Role of Group IIC-attCIntrons in Integron Cassette Formation
Léon, G., & Roy, P. H. (2009) · Journal of Bacteriology · doi:10.1128/jb.00674-09 · Cited by 37
Self-citationMaster, R. N., Deane, J., Opiela, C., & Sahm, D. F. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12022 · Cited by 26
Cited by
Horcajada, J. P., Montero, M., Oliver, A., Sorlí, L., Luque, S., Gómez-Zorrilla, S., Benito, N., & Grau, S. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-19 · Cited by 961
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
Ellington, M. J., Ekelund, O., Aarestrup, F. M., Canton, R., Doumith, M., Giske, C., Grundman, H., Hasman, H., Holden, M. T. G., Hopkins, K. L., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.11.012 · Cited by 603
Antibiotic resistance in Pseudomonas aeruginosa – Mechanisms, epidemiology and evolution
Botelho, J., Grosso, F., & Peixe, L. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.07.002 · Cited by 550
Mechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
Metadata
- Authors
- Kos, V. N., Déraspe, M., McLaughlin, R. E., Whiteaker, J. D., Roy, P. H., Alm, R. A., Corbeil, J., & Gardner, H.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2015-01
- Volume
- 59
- Issue
- 1
- Pages
- 427-436
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2133740160
- Cited by
- 264
- References
- 71
- FWCI
- 8.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.